Epigenetic Modifiers as Novel Therapeutic Targets and a Systematic Review of Clinical Studies Investigating Epigenetic Inhibitors in Head and Neck Cancer

SIMPLE SUMMARY: Head and neck cancer is the sixth most common malignancy worldwide and it affects approximately 50,000 patients annually in the United States. Current treatments are suboptimal and induce significant long-term toxicities that permanently affect quality of life. Novel therapeutic appr...

Descripción completa

Detalles Bibliográficos
Autores principales: Burkitt, Kyunghee, Saloura, Vassiliki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8534083/
https://www.ncbi.nlm.nih.gov/pubmed/34680389
http://dx.doi.org/10.3390/cancers13205241

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8534083/
https://www.ncbi.nlm.nih.gov/pubmed/34680389
http://dx.doi.org/10.3390/cancers13205241

Ejemplares similares